Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosomepositive acute lymphoblastic leukemia

J. H. Yoon, H. Y. Yhim, J. Y. Kwak, J. S. Ahn, D. H. Yang, J. J. Lee, S. J. Kim, J. S. Kim, S. J. Park, C. W. Choi, H. S. Eom, S. K. Park, S. Y. Choi, S. H. Kim, D. W. Kim, S. Lee

    Research output: Contribution to journalArticlepeer-review

    33 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosomepositive acute lymphoblastic leukemia'. Together they form a unique fingerprint.

    Medicine & Life Sciences